Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, September 26, 2013

NeuralStem Inc. CEO to Present at

The company has received FDA approval to commence a Phase I safety trial in chronic spinal cord injury.

http://www.biospace.com/news_story.aspx?StoryID=309838&full=1

No comments:

Post a Comment

Popular Stem Cell Roundup Posts